Stock Price Quote

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE3044.50131.55 (+4.52 %)
PREV CLOSE ( ) 2912.95
OPEN PRICE ( ) 2919.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2597
TODAY'S LOW / HIGH ( )2919.55 3100.00
52 WK LOW / HIGH ( )1635.3 3373.95
NSE3053.00142.55 (+4.9 %)
PREV CLOSE( ) 2910.45
OPEN PRICE ( ) 2919.00
BID PRICE (QTY) 3053.00 (638)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 69829
TODAY'S LOW / HIGH( ) 2902.95 3101.00
52 WK LOW / HIGH ( )1632.55 3375
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagandeep Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX

NEWS

13Mar Wipro, SBI and Infosys to see some act
Wipro has entered into an agreement with SAP SE to jointly go to market..
13Mar AstraZeneca Pharma gets permission fro
AstraZeneca Pharma India has received Import and Market permission in Fo..
13Mar AstraZeneca Pharma jumps on getting pe
Astrazeneca Pharma India is currently trading at Rs. 2305.00, up by 48.8..
24Feb AstraZeneca Pharma launches QTERN tabl
AstraZeneca Pharma India has launched FDC of Dapagliflozin 10mg + Saxagl..
24Feb AstraZeneca Pharma gains on launching
Astrazeneca Pharma India is currently trading at Rs. 2813.50, up by 11.3..

Financials

in Millions
QTR Mar 20 ANNUAL 20
Net Profit95.7799999999997722.1
Gross Profit 133.52 1139.6
Operating Profit 181.831336.81
Net Sales 1949.028318.09

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddys Lab (BSE)
peergroup  4073.80 (4.76%)
M.Cap ( in Cr)67695.18
Abbott India (BSE)
peergroup  16728.05 (0.80%)
M.Cap ( in Cr)35545.94
Divis Lab (BSE)
peergroup  2395.75 (4.92%)
M.Cap ( in Cr)63599.64
Solara Active Pharma (BSE)
peergroup  517.20 (9.70%)
M.Cap ( in Cr)1388.95
Ajanta Pharma (BSE)
peergroup  1523.60 (2.59%)
M.Cap ( in Cr)13295.13

Shareholding Pattern

PROMOTERS 75%
MUTUAL FUNDS/UTI 3.45%
NON-INSTITUTION 20.12%
FI/BANKS/INSURANCE 0.11%
GOVERNMENT 0%
FII 0%

About Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd. was incorporated in the year 1979. Its today's share price is 3044.5. Its current market capitalisation stands at Rs 7611.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 7282.9 Cr and Total Income of Rs.7445.8 Cr. The company's management includes Rajesh Marwaha, Gagandeep Singh Bedi, Weiying Sarah Wang, Ian John Parish, Kimsuka Narsimhan, Revathy Ashok, Narayan K Seshadri.

It is listed on the BSE with a BSE Code of 506820 , NSE with an NSE Symbol of ASTRAZEN and ISIN of INE203A01020. It's Registered office is at Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring RoadBengaluru-560045, Karnataka. Their Registrars are ACC Ltd. It's auditors are AF Ferguson & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X